LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 9 of total 9

Search options

  1. Article ; Online: Data for crystallisation, dissolution and saturation temperatures of a model fuel comprising eicosane crystallising from supersaturated toluene solutions in the presence of a cold-flow improver additive

    Peter L. Kaskiewicz / Ruth Downie / Peter J. Dowding / Neil George / Kevin J. Roberts

    Data in Brief, Vol 43, Iss , Pp 108455- (2022)

    2022  

    Abstract: The data presented in this article relates to the crystallisation of the long chain hydrocarbon eicosane (C20H42), from supersaturated toluene solutions in the absence/presence of a commercially available cold-flow improver additive (IA) at different ... ...

    Abstract The data presented in this article relates to the crystallisation of the long chain hydrocarbon eicosane (C20H42), from supersaturated toluene solutions in the absence/presence of a commercially available cold-flow improver additive (IA) at different solution treat rates. Data was collected for treat rates of 0, 0.1, 0.5, 2, 3, 5 and 10 wt% IA with respect to eicosane, with each treat rate studied over four solution concentrations. Data is collected by transmission vs. solution temperature experimental investigations and is analysed through a conventional transmission analysis route (STR) and a reanalysed route that takes into account multiple phase transformation behaviour (RRT). Average crystallisation and dissolution data is provided over a range of solution concentrations and cooling rates used under a polythermal crystallisation methodology for each analysis route. Equilibrium saturation temperature, supersolubility and metastable zone width data is also presented for each treat rate, concentration and analysis route. Laser transmission as a function of solution temperature profiles are displayed for IA crystallising from toluene solutions. This data relates to the research article: Kaskiewicz, P. L., Downie, R., Dowding, P. J., George, N. & Roberts, K. J. Influence of a Polymeric Additive on the Crystallisability and Nucleation Mechanism for the Model Fuel System of Eicosane Crystallising from Supersaturated Toluene Solutions. J. Cryst. Growth 581, (2021) 126,470. https://doi.org/10.1016/j.jcrysgro.2021.126470
    Keywords Crystallization ; Fuel ; Additive ; Solubility ; Turbidity ; Computer applications to medicine. Medical informatics ; R858-859.7 ; Science (General) ; Q1-390
    Subject code 669
    Language English
    Publishing date 2022-08-01T00:00:00Z
    Publisher Elsevier
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  2. Article ; Online: Data on the intermolecular interactions of 1,1,1,2-tetrafluoroethane liquids from molecular dynamics simulations

    Chin W. Yong / Vivian Walter Barron / Alex Slowey / Ilian T. Todorov / Kevin J. Roberts / Robert B. Hammond

    Data in Brief, Vol 50, Iss , Pp 109485- (2023)

    2023  

    Abstract: Detailed atomistic interactions of 1,1,1,2-tetrafluoroethane (HFA-134a) liquid were presented in a data format, namely, DL_ANALYSER Notation for Atomic Interactions (DANAI), that annotates precisely the nature of interactions that is discoverable and ... ...

    Abstract Detailed atomistic interactions of 1,1,1,2-tetrafluoroethane (HFA-134a) liquid were presented in a data format, namely, DL_ANALYSER Notation for Atomic Interactions (DANAI), that annotates precisely the nature of interactions that is discoverable and searchable without having to resolve to diagrammatic illustrations. The datasets were obtained from raw atomic trajectory files of HFA-134a pure liquid models produced by using DL_POLY molecular dynamics software package. The trajectory datafiles contain expressions of atomic species in a natural chemical sense, and hence, provide localized key interactions, ‘at a glance’, of the liquid model on otherwise a typically disordered system consists of complex network of intermolecular interactions. The data provide insights to detailed structural behavior of molecules in liquid phase, and can be used as cheminformatics comparative investigations, linking to other molecular system models that contain similar interaction types and chemical species. This can form the foundation of investigations into the role of HFA-134a plays within different applications. For example, it can be used to compare structural and atomic interaction differences with alternative refrigerants, or as liquid propellants in pharmaceutical devices when solvating formulation ingredients.
    Keywords HFA-134a ; Atomic interactions ; Molecular dynamics ; DL_ANALYSER ; DANAI ; Hydrogen bonds ; Computer applications to medicine. Medical informatics ; R858-859.7 ; Science (General) ; Q1-390
    Subject code 541
    Language English
    Publishing date 2023-10-01T00:00:00Z
    Publisher Elsevier
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article ; Online: The influence of solid state information and descriptor selection on statistical models of temperature dependent aqueous solubility

    Richard L. Marchese Robinson / Kevin J. Roberts / Elaine B. Martin

    Journal of Cheminformatics, Vol 10, Iss 1, Pp 1-

    2018  Volume 21

    Abstract: Abstract Predicting the equilibrium solubility of organic, crystalline materials at all relevant temperatures is crucial to the digital design of manufacturing unit operations in the chemical industries. The work reported in our current publication ... ...

    Abstract Abstract Predicting the equilibrium solubility of organic, crystalline materials at all relevant temperatures is crucial to the digital design of manufacturing unit operations in the chemical industries. The work reported in our current publication builds upon the limited number of recently published quantitative structure–property relationship studies which modelled the temperature dependence of aqueous solubility. One set of models was built to directly predict temperature dependent solubility, including for materials with no solubility data at any temperature. We propose that a modified cross-validation protocol is required to evaluate these models. Another set of models was built to predict the related enthalpy of solution term, which can be used to estimate solubility at one temperature based upon solubility data for the same material at another temperature. We investigated whether various kinds of solid state descriptors improved the models obtained with a variety of molecular descriptor combinations: lattice energies or 3D descriptors calculated from crystal structures or melting point data. We found that none of these greatly improved the best direct predictions of temperature dependent solubility or the related enthalpy of solution endpoint. This finding is surprising because the importance of the solid state contribution to both endpoints is clear. We suggest our findings may, in part, reflect limitations in the descriptors calculated from crystal structures and, more generally, the limited availability of polymorph specific data. We present curated temperature dependent solubility and enthalpy of solution datasets, integrated with molecular and crystal structures, for future investigations.
    Keywords Quantitative structure–property relationships ; Solubility ; Temperature dependent solubility data ; Enthalpy of solution ; Machine learning ; Random forest ; Information technology ; T58.5-58.64 ; Chemistry ; QD1-999
    Subject code 669
    Language English
    Publishing date 2018-08-01T00:00:00Z
    Publisher BMC
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  4. Article: Solubility and Nucleation of Methyl Stearate as a Function of Crystallization Environment

    Camacho, Diana M / Iain More / Ken Lewtas / Kevin J. Roberts

    Energy & fuels. 2018 Feb. 20, v. 32, no. 3

    2018  

    Abstract: Crystallization studies of methyl stearate from supersaturated dodecane, kerosene, and toluene solutions reveal strong evidence that solvent choice influences solubility and nucleation behavior. Solute solubility is less than ideal with toluene, kerosene, ...

    Abstract Crystallization studies of methyl stearate from supersaturated dodecane, kerosene, and toluene solutions reveal strong evidence that solvent choice influences solubility and nucleation behavior. Solute solubility is less than ideal with toluene, kerosene, and dodecane, respectively, exhibiting the closest behavior to ideality, the latter consistent with the highest solvation. Polythermal crystallization studies using the Kashchiev–Borissova–Hammond–Roberts (KBHR) model [Kashchiev et al. J. Phys. Chem. B2010, 114, 5441; Kashchiev et al. J. Cryst. Growth2010, 312, 698; Camacho et al. CrystEngComm2014, 16, 974] reveal a progressive nucleation (PN) mechanism with crystallite interfacial tension (γeff) values between 0.94 and 1.55 mJ/m2, between 1.21 and 1.91 mJ/m2, and between 1.18 and 1.88 mJ/m2 for dodecane, kerosene, and toluene, respectively. Nucleation rates at the critical undercooling lie between 4.56 × 1016 and 1.79 × 1017 nuclei/mL·s, with the highest rates associated with crystallization from kerosene solutions. Iso-supersaturation nucleation rates are the highest for dodecane ranging from 2.39 × 1017 to 3.63 × 1018 nuclei/mL·s. Nucleation in toluene appears to be hindered by its relatively higher interfacial tension, which is associated with nucleation rates about an order of magnitude less than those obtained for dodecane.
    Keywords crystallites ; crystallization ; kerosene ; models ; solubility ; solutes ; solvents ; stearic acid ; surface tension ; toluene
    Language English
    Dates of publication 2018-0220
    Size p. 3447-3459.
    Publishing place American Chemical Society
    Document type Article
    ZDB-ID 1483539-3
    ISSN 1520-5029 ; 0887-0624
    ISSN (online) 1520-5029
    ISSN 0887-0624
    DOI 10.1021/acs.energyfuels.7b03212
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  5. Article: Process-Focused Synthesis, Crystallization, and Physicochemical Characterization of Sodium Lauroyl Isethionate

    Jeraal, Mohammed I / David Harbottle / Ian McRobbie / Kevin J. Roberts

    ACS sustainable chemistry & engineering. 2018 Feb. 05, v. 6, no. 2

    2018  

    Abstract: There is a notable lack of published data concerning sodium cocoyl isethionate despite widespread application in the personal care industry. A specific homologue, sodium lauroyl isethionate (SLI), was therefore synthesized, purified by recrystallization, ...

    Abstract There is a notable lack of published data concerning sodium cocoyl isethionate despite widespread application in the personal care industry. A specific homologue, sodium lauroyl isethionate (SLI), was therefore synthesized, purified by recrystallization, and then subjected to a detailed physicochemical examination. A purity of 98% was achieved via repeat recrystallization in methanol. A turbidimetric solubility analysis was then executed to identify both its crystallizability and metastable zone width as a function of temperature. Thermogravimetric analysis yielded decomposition onsets of 330 °C for the purified SLI. A dynamic vapor sorption study also demonstrated reversibility in the 2.3% mass gained when it was exposed to sustained humidity of 87%. Surface tension measurements of purified SLI yielded a critical micellar concentration (CMC) of 5.4 mM and a plateau surface tension of 38 mN/m at 20 °C. Both values are lower than the previously reported values for SLI in water, thus indicating the performance benefits of purified isethionates in personal care formulations. The single step synthesis was chlorine-, catalyst-, and solvent-free, thus improving process efficiency, safety, and throughput over existing SLI syntheses. The succeeding physicochemical analysis crucially provides much needed insight into the purification, properties, and performance of isethionate ester surfactants, all of which are strongly applicable to their commercial manufacture from biorenewable sources.
    Keywords crystallization ; dynamic vapor sorption method ; humidity ; manufacturing ; methanol ; sodium ; solubility ; surface tension ; surfactants ; temperature ; thermogravimetry
    Language English
    Dates of publication 2018-0205
    Size p. 2667-2675.
    Publishing place American Chemical Society
    Document type Article
    ISSN 2168-0485
    DOI 10.1021/acssuschemeng.7b04237
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  6. Article ; Online: Data for crystallisation, dissolution and saturation temperatures of the ternary system

    Xue Tang / Peter L. Kaskiewicz / Diana M. Camacho Corzo / Xiaojun Lai / Kevin J. Roberts / Peter Dowding / Iain More

    Data in Brief, Vol 19, Iss , Pp 1382-

    Hexadecane and octadecane representative in fuel solvents

    2018  Volume 1392

    Abstract: The data presented in this article relates to the crystallisation of hexadecane (C16H34) and octadecane (C18H38), being the predominant alkanes present in hydrotreated vegetable oil (HVO), from solvents representative of fuel (dodecane, toluene and ... ...

    Abstract The data presented in this article relates to the crystallisation of hexadecane (C16H34) and octadecane (C18H38), being the predominant alkanes present in hydrotreated vegetable oil (HVO), from solvents representative of fuel (dodecane, toluene and kerosene). Data was collected for eleven C16H34/C18H38 compositions for each solvent used. Raw crystallisation and dissolution data is provided over a range of solution concentrations and cooling rates used under a poly-thermal crystallisation methodology. Equilibrium saturation temperature data is also presented for each composition, concentration and solvent system, indicating the trend in solubility for each solution.
    Keywords Computer applications to medicine. Medical informatics ; R858-859.7 ; Science (General) ; Q1-390
    Language English
    Publishing date 2018-08-01T00:00:00Z
    Publisher Elsevier
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article ; Online: Preclinical development of a bispecific TNFα/IL-23 neutralising domain antibody as a novel oral treatment for inflammatory bowel disease

    Kevin J. Roberts / Marion F. Cubitt / Timothy M. Carlton / Lurdes Rodrigues-Duarte / Luana Maggiore / Ray Chai / Simon Clare / Katherine Harcourt / Thomas T. MacDonald / Keith P. Ray / Anna Vossenkämper / Michael R. West / J. Scott Crowe

    Scientific Reports, Vol 11, Iss 1, Pp 1-

    2021  Volume 14

    Abstract: Abstract Anti-TNFα and anti-IL-23 antibodies are highly effective therapies for Crohn’s disease or ulcerative colitis in a proportion of patients. V56B2 is a novel bispecific domain antibody in which a llama-derived IL-23p19-specific domain antibody, ... ...

    Abstract Abstract Anti-TNFα and anti-IL-23 antibodies are highly effective therapies for Crohn’s disease or ulcerative colitis in a proportion of patients. V56B2 is a novel bispecific domain antibody in which a llama-derived IL-23p19-specific domain antibody, humanised and engineered for intestinal protease resistance, V900, was combined with a previously-described TNFα-specific domain antibody, V565. V56B2 contains a central protease-labile linker to create a single molecule for oral administration. Incubation of V56B2 with trypsin or human faecal supernatant resulted in a complete separation of the V565 and V900 monomers without loss of neutralising potency. Following oral administration of V900 and V565 in mice, high levels of each domain antibody were detected in the faeces, demonstrating stability in the intestinal milieu. In ex vivo cultures of colonic biopsies from IBD patients, treatment with V565 or V900 inhibited tissue phosphoprotein levels and with a combination of the two, inhibition was even greater. These results support further development of V56B2 as an oral therapy for IBD with improved safety and efficacy in a greater proportion of patients as well as greater convenience for patients compared with traditional monoclonal antibody therapies.
    Keywords Medicine ; R ; Science ; Q
    Subject code 610
    Language English
    Publishing date 2021-09-01T00:00:00Z
    Publisher Nature Portfolio
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  8. Article ; Online: Preclinical Development of a Novel, Orally-Administered Anti-Tumour Necrosis Factor Domain Antibody for the Treatment of Inflammatory Bowel Disease

    J. Scott Crowe / Kevin J. Roberts / Timothy M. Carlton / Luana Maggiore / Marion F. Cubitt / Simon Clare / Katherine Harcourt / Jill Reckless / Thomas T. MacDonald / Keith P. Ray / Anna Vossenkämper / Michael R. West

    Scientific Reports, Vol 8, Iss 1, Pp 1-

    2018  Volume 13

    Abstract: Abstract TNFα is an important cytokine in inflammatory bowel disease. V565 is a novel anti-TNFα domain antibody developed for oral administration in IBD patients, derived from a llama domain antibody and engineered to enhance intestinal protease ... ...

    Abstract Abstract TNFα is an important cytokine in inflammatory bowel disease. V565 is a novel anti-TNFα domain antibody developed for oral administration in IBD patients, derived from a llama domain antibody and engineered to enhance intestinal protease resistance. V565 activity was evaluated in TNFα-TNFα receptor-binding ELISAs as well as TNFα responsive cellular assays and demonstrated neutralisation of both soluble and membrane TNFα with potencies similar to those of adalimumab. Although sensitive to pepsin, V565 retained activity after lengthy incubations with trypsin, chymotrypsin, and pancreatin, as well as mouse small intestinal and human ileal and faecal supernatants. In orally dosed naïve and DSS colitis mice, high V565 concentrations were observed in intestinal contents and faeces and immunostaining revealed V565 localisation in mouse colon tissue. V565 was detected by ELISA in post-dose serum of colitis mice, but not naïve mice, demonstrating penetration of disrupted epithelium. In an ex vivo human IBD tissue culture model, V565 inhibition of tissue phosphoprotein levels and production of inflammatory cytokine biomarkers was similar to infliximab, demonstrating efficacy when present at the disease site. Taken together, results of these studies provide confidence that oral V565 dosing will be therapeutic in IBD patients where the mucosal epithelial barrier is compromised.
    Keywords Medicine ; R ; Science ; Q
    Subject code 610
    Language English
    Publishing date 2018-03-01T00:00:00Z
    Publisher Nature Publishing Group
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  9. Article ; Online: Oral Anti-Tumour Necrosis Factor Domain Antibody V565 Provides High Intestinal Concentrations, and Reduces Markers of Inflammation in Ulcerative Colitis Patients

    Suhail Nurbhai / Kevin J. Roberts / Timothy M. Carlton / Luana Maggiore / Marion F. Cubitt / Keith P. Ray / Jill Reckless / Hafeez Mohammed / Peter Irving / Thomas T. MacDonald / Anna Vossenkämper / Michael R. West / Gareth C. Parkes / J. Scott Crowe

    Scientific Reports, Vol 9, Iss 1, Pp 1-

    2019  Volume 12

    Abstract: Abstract V565 is an engineered TNFα-neutralising single domain antibody formulated into enteric coated mini-tablets to enable release in the intestine after oral administration as a possible oral treatment for inflammatory bowel disease (IBD). Following ... ...

    Abstract Abstract V565 is an engineered TNFα-neutralising single domain antibody formulated into enteric coated mini-tablets to enable release in the intestine after oral administration as a possible oral treatment for inflammatory bowel disease (IBD). Following oral administration, ileal recovery of V565 was investigated in four patients with terminal ileostomy. Intestinal and systemic pharmacokinetics were measured in six patients with Crohn’s disease and evidence of target engagement assessed in five patients with ulcerative colitis. Following oral administration, V565 was detected at micromolar concentrations in ileal fluid from the ileostomy patients and in stools of the Crohn’s patients. In four of the five ulcerative colitis patients, biopsies taken after 7d dosing demonstrated V565 in the lamina propria with co-immunostaining on CD3+ T-lymphocytes and CD14+ macrophages. Phosphorylation of signalling proteins in biopsies taken after 7d oral dosing was decreased by approximately 50%. In conclusion, enteric coating of V565 mini-tablets provided protection in the stomach with gradual release in intestinal regions affected by IBD. Immunostaining revealed V565 tissue penetration and association with inflammatory cells, while decreased phosphoproteins after 7d oral dosing was consistent with V565-TNFα engagement and neutralising activity. Overall these results are encouraging for the clinical utility of V565 in the treatment of IBD.
    Keywords Medicine ; R ; Science ; Q
    Subject code 610
    Language English
    Publishing date 2019-10-01T00:00:00Z
    Publisher Nature Publishing Group
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top